Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 Study

1. Chung, H.C.
2. Saada-Bouzid, E.
3. Longo, F.
4. Yanez, E.
5. Im, S.-A.
6. Castanon, E.
7. Desautels, D.N.
8. Graham, D.M.
9. Garcia-Corbacho, J.
10. Lopez, J.
11. Dutcus, C.
12. Okpara, C.E.
13. Ghori, R.
14. Jin, F.
15. Groisberg, R.
16. Korakis, I.